共 42 条
[1]
Lipton RB(2013)The international classification of headache disorders, 3rd edition (beta version) Cephalalgia 33 629-808
[2]
Varon SF(2011)OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine Neurology 77 1465-1472
[3]
Grosberg B(2016)Impact of migraine on the family: perspectives of people with migraine and their spouse/domestic partner in the CaMEO study Mayo Clin Proc 91 596-611
[4]
McAllister PJ(2008)Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment Neurology 71 559-566
[5]
Freitag F(2011)OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program Headache 51 1358-1373
[6]
Aurora SK(2010)OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program Headache 50 921-936
[7]
Dodick DW(2006)Prophylaxis of migraine Neuropsychiatr Dis Treat 2 281-291
[8]
Silberstein SD(undefined)undefined undefined undefined undefined-undefined
[9]
Diener HC(undefined)undefined undefined undefined undefined-undefined
[10]
DeGryse RE(undefined)undefined undefined undefined undefined-undefined